CBDepot Group starts the marketing of synthesized pharma-grade CBD produced under the EU GMP umbrella of its sister company CB21 Pharma, s.r.o. During the CPhI 2017 event in Frankfurt, CBDepot introduced, as the first company […]
SMi Reports: Leading pharmaceutical microbiologists and industry experts to meet at SMi’s 10th Anniversary Pharmaceutical Microbiology UK Conference taking place in London on 17-18 January 2022. SMi Group announces the 10th Annual Pharmaceutical Microbiology UK […]
The Gx Elite vials are a solution that sets new standards for type I borosilicate glass packaging. They are the result of comprehensive improvement and optimization measures in the tube draw and vial forming processes. […]
AstraZeneca has entered an agreement to partner with VaxEquity to discover, develop and market the proprietary self-amplifying ribonucleic acid (saRNA) therapeutics platform created at Imperial College London in the UK. The strategic, long-term research partnership […]
Sanofi has concluded the acquisition of messenger RNA (mRNA) therapies company, Translate Bio, for $38 per share in cash, representing a total equity value of nearly $3.2bn, on a fully diluted basis. Last month, Sanofi […]